Article thumbnail

Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model

By Kristin M. Gehrking, J. Michael Andresen, Lisa Duvick, John Lough, Huda Y. Zoghbi and Harry T. Orr


Spinocerebellar ataxia type 1 (SCA1) is one of nine dominantly inherited neurodegenerative diseases caused by polyglutamine tract expansion. In SCA1, the expanded polyglutamine tract is in the ataxin-1 (ATXN1) protein. ATXN1 is part of an in vivo complex with retinoid acid receptor-related orphan receptor alpha (Rora) and the acetyltransferase tat-interactive protein 60 kDa (Tip60). ATXN1 and Tip60 interact directly via the ATXN1 and HMG-box protein 1 (AXH) domain of ATXN1. Moreover, the phospho-mimicking Asp amino acid at position 776, previously shown to enhance pathogenesis, increases the ability of ATXN1 to interact with Tip60. Using a genetic approach, the biological relevance of the ATXN1/Tip60 interaction was assessed by crossing ATXN1[82Q] mice with Tip60+/−animals. Partial Tip60 loss increased Rora and Rora-mediated gene expression and delayed ATXN1[82]-mediated cerebellar degeneration during mid-stage disease progression. These results suggested a specific, temporal role for Tip60 during disease progression. We also showed that genetic background modulated ATXN1[82Q]-induced phenotypes. Of interest, these latter studies showed that some phenotypes are enhanced on a mixed background while others are suppressed

Topics: Articles
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2005). Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort.
  2. (2006). ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.
  3. (2003). ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
  4. (1998). Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.
  5. (1996). Cloning and developmental expression analysis of the murine homolog of the spinocerebellar ataxia type 1 gene (Sca1).
  6. (1996). Disruption of the nuclear hormone receptor RORalpha in staggerer mice.
  7. (2007). Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1.
  8. (2008). Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6.
  9. (1993). Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.
  10. (1995). Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals.
  11. (2009). Homozygous disruption of the Tip60 gene causes early embryonic lethality.
  12. (1997). Identification of a self-association region within the SCA1 gene product,
  13. (2003). Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.
  14. (2008). Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.
  15. (2010). Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.
  16. (1997). Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations.
  17. (2004). Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.
  18. (2005). RNA association and nucleocytoplasmic shuttling by ataxin-1.
  19. (2003). RORalpha coordinates reciprocal signaling in cerebellar development through sonic hedgehog and calcium-dependent pathways.
  20. (2006). RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
  21. (1995). SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.
  22. (2010). SCA1-like disease in mice expressing wild type ataxin-1 with a serine to aspartic acid replacement at residue 776.
  23. (1962). Staggerer, a new mutation in the mouse affecting the cerebellum.
  24. (2005). The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/senseless proteins.
  25. (2003). The AXH module: an independently folded domain common to ataxin-1 and HBP1.
  26. (2001). The expression of vesicular glutamate transporters defines two classes of excitatory synapse.
  27. (2003). The MYST family of histone acetyltransferases.
  28. (2005). The pathogenesis of spinocerebellar ataxia.
  29. (2001). The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
  30. (2004). The structure of the AXH domain of spinocerebellar ataxin-1.
  31. (2002). Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor.
  32. (1999). Tip60 is a nuclear hormone receptor coactivator.
  33. (2007). Trinucleotide repeat disorders.